Savara (SVRA) Cash & Equivalents (2010 - 2026)

Savara (SVRA) reported Cash & Equivalents of $38.8 million for Q1 2026, up 97.96% year-over-year from $19.6 million in Q1 2025, and up 16.94% quarter-over-quarter from $33.2 million in Q4 2025.

Savara (SVRA) Cash & Equivalents (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Cash & Equivalents data on file, last reported at $38.8 million in Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $38.8 million, up 97.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.8 million (up 97.96% YoY), and the FY2025 annual result was $33.2 million, up 119.33% from the prior year.
  • Cash & Equivalents climbed to $38.8 million in Q1 2026 per SVRA's latest filing, from $33.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $119.8 million in Q3 2022 and troughed at $15.1 million in Q4 2024.
  • A 5-year average of $38.8 million and a median of $26.6 million in 2023 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 168.1% in 2022, then slumped 76.89% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $52.1 million in 2022, then sank by 48.97% to $26.6 million in 2023, then tumbled by 43.1% to $15.1 million in 2024, then surged by 119.33% to $33.2 million in 2025, then rose by 16.94% to $38.8 million in 2026.
  • Business Quant data shows SVRA's Cash & Equivalents at $38.8 million in Q1 2026, $33.2 million in Q4 2025, and $16.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Savara 1.39 Bn 1.39 Bn - 38.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.80 Mn
Dec 31, 2025 33.18 Mn
Sep 30, 2025 16.28 Mn
Jun 30, 2025 17.40 Mn
Mar 31, 2025 19.60 Mn
Dec 31, 2024 15.13 Mn
Sep 30, 2024 21.43 Mn
Jun 30, 2024 23.90 Mn
Mar 31, 2024 16.80 Mn
Dec 31, 2023 26.59 Mn
Sep 30, 2023 27.69 Mn
Jun 30, 2023 22.70 Mn
Mar 31, 2023 33.98 Mn
Dec 31, 2022 52.10 Mn
Sep 30, 2022 119.84 Mn
Jun 30, 2022 95.15 Mn
Mar 31, 2022 79.20 Mn
Dec 31, 2021 34.01 Mn
Sep 30, 2021 44.70 Mn
Jun 30, 2021 40.70 Mn